29, 1-st Brestskaya Street,

Business-center "Capital Tower", level 8

Moscow, Russia, 125047 

+7 495 545-39-12

Создано с помощью инструментов Яндекс.Карт

Media Center

  • 20 April 2018

    Start-up pushes for artificial intelligence to support medical diagnostics

    eleMD, a Russian start-up, is developing a software platform that uses artificial intelligence (AI) for cancer diagnostics and prognostication. Over the past few months the start-up has been focused on fine-tuning the platform’s image recognition functionality for cancer diagnostics, and also on making the solution scalable for medical specialists from across disciplines to be able to analyze heterogeneous medical data. 

  • 20 April 2018

    Small biotech companies rule in development of microbiome-targeted therapeutics

    According to leading data and analytics company GlobalData, with smaller biotech companies dominating the pipeline for microbiome-targeted therapeutics, large pharma firms, such as Johnson & Johnson, are eager to collaborate with biotech companies and academic labs to further the development of microbiome-targeted therapeutics in immunology.

  • 19 April 2018

    Can CAR-T and gene therapy cures really sustain biopharma? Not for all, analyst says

    Ever since 2012 when Novartis invested in personalized CAR-T cancer treatments being developed at the University of Pennsylvania, analysts have pondered a difficult question: How can pharma companies profit from curing patients?

  • 18 April 2018

    SID & GP: many Russian pharma companies outdo their foreign counterparts

    According to Vladimir Orlov, Deputy Head of the Educational Center for Good Practices, State Institute of Drugs and Good Practices (SID & GP), a federal budgetary institution, the inspections and checks conducted in major foreign pharmaceutical companies have a great importance for the development of Russian drug manufacturing industry.

Read more